Summary:
- Amperos Health, a NYC-based company, secured $4.2M in Seed funding for their AI biller, Amanda, designed for healthcare providers.
- The funding round was led by Uncork Capital, Neo, and Nebular, with support from strategic angel investors from OpenAI, Twilio, and Stripe.
- Amperos Health plans to use the funds to enhance Amanda’s capabilities, introduce new AI coworkers for RCM teams, and expand support for various healthcare providers.
Article:
Amperos Health Raises $4.2M in Seed Funding for AI Healthcare Billing Solution
Amperos Health, a leading company based in New York City, has recently announced a significant milestone in its journey towards revolutionizing healthcare billing. The company successfully secured $4.2 million in Seed funding for its innovative AI biller, Amanda, tailored specifically for healthcare providers.
This funding round was made possible through the support of prominent investors such as Uncork Capital, Neo, and Nebular, as well as strategic angel investors from esteemed companies like OpenAI, Twilio, and Stripe. With this latest injection of capital, Amperos Health’s total funding to date now stands at an impressive $5 million.
The primary objective behind this fundraising effort is to further enhance Amanda’s capabilities and introduce new AI coworkers for Revenue Cycle Management (RCM) teams. Additionally, Amperos Health aims to expand its support for a broader range of customers, including inpatient, outpatient, Dental Service Organizations (DSO), and Durable Medical Equipment (DME) providers.
At the helm of Amperos Health is CEO Michal Miernowski, a visionary leader driving the company’s mission to empower healthcare providers in combating denials and streamlining claims collections. Amanda, the flagship product of Amperos Health, is a multi-modal AI biller equipped with advanced security measures to ensure full HIPAA compliance.
Amanda’s unique capabilities extend across various systems and tasks, from navigating insurance websites to communicating with payors, enabling providers to efficiently reverse denials and expedite payment on outstanding claims. By leveraging cutting-edge AI technology, Amperos Health is empowering RCM teams to resolve more denials, recover additional revenue, and enhance overall productivity.
As Amperos Health continues to innovate and expand its reach within the healthcare industry, the company remains committed to delivering tailored solutions that drive efficiency, accuracy, and profitability for healthcare providers nationwide.
Conclusion:
In conclusion, Amperos Health’s recent fundraising success is a testament to the company’s dedication to revolutionizing the healthcare billing landscape through innovative AI solutions. With a clear focus on enhancing Amanda’s capabilities and expanding support for diverse healthcare providers, Amperos Health is well-positioned to drive meaningful change within the industry.
